American Association for Cancer Research

SHERPA: White

People

  1. O'Reilly
    O'Reilly
  2. Drilon
    Drilon
  3. Ladanyi
    Ladanyi
  4. Schram
    Schram
  5. Torrisi
    Torrisi
  6. Chakravarty
    Chakravarty
  7. De Stanchina
    De Stanchina
  8. Espinosa Cotton
    Espinosa Cotton
  9. Gonen
    Gonen
  10. Hong
    Hong

Groups

  1. Center for Pancreatic Cancer Research (4)
  2. Department of Medicine (4)
  3. Gastrointestinal Oncology Service (4)
  4. Solid Tumor Oncology Division (4)
  5. GSK Faculty (3)
  6. Human Oncology and Pathogenesis Program (3)
  7. Sloan Kettering Institute Postdocs (3)
  8. Body Imaging Service (2)
  9. Early Drug Development Service (2)
  10. Gynecologic Medicine Service (2)
Search Within
  1. "Eileen O'Reilly"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Center for Pancreatic Cancer Research (4)
  2. Department of Medicine (4)
  3. Gastrointestinal Oncology Service (4)
  4. Solid Tumor Oncology Division (4)
  5. GSK Faculty (3)
  6. Human Oncology and Pathogenesis Program (3)

More Groups

People
  1. Eileen O'Reilly (4)
  2. Alexander Drilon (2)
  3. Alison Schram (2)
  4. Jean Torrisi (2)
  5. Marc Ladanyi (2)
  6. Romel Somwar (2)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2001 (1)
Publications
  1. Cancer Discovery (2)
  2. Molecular Cancer Therapeutics (1)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • The evolutionary origins of recurrent pancreatic cancer
    Journal Article

    Sakamoto, H.; Attiyeh, M. A.; Gerold, J. M.; Makohon-Moore, A. P.; Hayashi, A.; Hong, J.; Kappagantula, R.; Zhang, L.; Melchor, J. P.; Reiter, J. G.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • A phase IB clinical trial of the sequence dependent combination of paclitaxel (P) and cisplatin (C) with the cyclin dependent kinase (CDK) inhibitor flavopiridol in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kaubisch, A.; O'reilly, E.; Sharma, S.; Endres, S.; Welch, M.; Tong, W.; Spriggs, D.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save